The Nurse practitionerHumansDrug ApprovalUnited StatesUnited States Food and Drug AdministrationCrohn Disease
The Drug Update: Recent drug approvals, winter 2026 edition.
Adriane B Marino, Jenna D Theroux, Evan S Drake, Kendra Gemmill Hofler, Trent Long
Published: 202610.1097/01.NPR.0000000000000406
Abstract
ABSTRACT: In the first half of 2025, the US FDA approved several new drugs that have relevance for those practicing in primary care. This article highlights the following new medications and vaccinations: suzetrigine (Journavx); gepotidacin (Blujepa)…
Preview only. Read the full abstract at the source